Kwang Dong Pharmaceutical Co., Ltd.

KSE 009290.KS

Kwang Dong Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 418.27 M

Kwang Dong Pharmaceutical Co., Ltd. Shareholders' Equity is USD 418.27 M for the year ending December 31, 2023, a 2.34% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Kwang Dong Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 408.69 M, a -2.18% change year over year.
  • Kwang Dong Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 417.81 M, a -4.72% change year over year.
  • Kwang Dong Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 438.49 M, a 20.27% change year over year.
  • Kwang Dong Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 364.59 M, a 0.62% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
KSE: 009290.KS

Kwang Dong Pharmaceutical Co., Ltd.

Description

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents. The company also provides general supplements, OTC drinks, consumer drinks, functional drinks, and traditional health foods. In addition, it engages in the operation of hospitals; and the retail and wholesale of products through discount stores, TV home shopping, and Internet shopping malls. Further, the company operates as a MRO total service provider for the raw/intermediate materials and consumables under various business models, such as the construction purchase service and overseas local purchase service. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.

Similar companies

000640.KS

Dong-A Socio Holdings Co., Ltd.

USD 65.38

-0.04%

007570.KS

Ilyang Pharmaceutical Co.,Ltd

USD 7.33

-4.07%

000100.KS

Yuhan Corporation

USD 83.97

-5.00%

003000.KS

Bukwang Pharmaceutical Co., Ltd.

USD 3.10

-3.13%

000020.KS

Dongwha Pharm.Co.,Ltd

USD 4.07

-1.95%

StockViz Staff

February 4, 2025

Any question? Send us an email